• Citigroup reaffirms bullish 6–12 month gold target of $5,000/oz, among the highest on Wall Street.
  • Near-term headwinds from Middle East uncertainty could fuel short-term selling, but risk-off demand provides a floor.
  • The bank’s 0–3 month target stands at $4,300/oz, reflecting a cautious near-term outlook.

Citi Bets on Gold’s Long-Term Rally Despite Short-Term Volatility

Citigroup has maintained its 6–12 month gold price target at $5,000 per ounce, a level that sits at the high end of analyst forecasts, even as the bank warns that escalating geopolitical tensions in the Middle East could spark near-term selling pressure.

“We see gold benefiting from persistent macro uncertainty and a potential reallocation to safe havens,” the bank’s commodity strategists wrote in a note. “However, in the very near term, Middle East headlines could trigger profit-taking and tactical selling.” The 0–3 month target remains unchanged at $4,300/oz.

The call underscores a split in the gold market: bullish long-term fundamentals, including central bank buying and inflation hedging, against short-lived risk-off episodes that can drive sharp but temporary declines.

Why Citi Stands Apart

Most major banks project gold in the $4,800–$5,000 range for 2026, but Citi’s $5,000 target represents one of the most optimistic scenarios. The bank’s confidence hinges on a sustained demand-supply rebalancing and a macro backdrop that could keep real yields low — a historical tailwind for gold.

A Citigroup spokesperson declined to comment further when reached. The note was distributed to clients earlier this week and reviewed by our team.

The Bigger Picture

Gold has had a strong run over the past year, buoyed by central bank purchases and geopolitical turmoil. Yet near-term volatility remains elevated, with prices swinging on every headline from the Middle East and shifts in US interest rate expectations. Citi’s view suggests that while short-term bumps are likely, the structural case for gold remains intact — a bet that has often paid off for patient investors.

Correction: An earlier version of this article misstated the 0–3 month target. It is $4,300/oz, not $4,500/oz.